Federal Trade Commission v. AbbVie Inc. (3d Cir. 2020)

Published date13 October 2020
Subject MatterFTC,ANDA,Patents,Prescription Drugs,Generic Drugs,Patent Litigation,Patent Infringement,FTCA Section 13(b)
AuthorKevin Noonan
Law FirmMcDonnell Boehnen Hulbert & Berghoff LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT